Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 5;44(7):3039-3052.
doi: 10.3390/cimb44070210.

Bioactive Compounds and Adipocyte Browning Phenomenon

Affiliations
Review

Bioactive Compounds and Adipocyte Browning Phenomenon

Josué Manríquez-Núñez et al. Curr Issues Mol Biol. .

Abstract

Overweight and obesity have become worldwide health issues in most countries. Current strategies aimed to prevent or reduce overweight and obesity have mainly focused on the genes and molecular mechanisms that give the functional characteristics to different types of adipose tissue. The Browning phenomenon in adipocytes consists of phenotypic and metabolic changes within white adipose tissue (WAT) activated by thermogenic mechanisms similar to that occurring in brown adipose tissue (BAT); this phenomenon has assumed great relevance due to its therapeutic potential against overweight and obesity. In addition, the study of inflammation in the development of overweight and obesity has also been included as a relevant factor, such as the pro-inflammatory mechanisms promoted by M1-type macrophages in adipose tissue. Studies carried out in this area are mainly performed by using the 3T3-L1 pre-adipocyte cell line, testing different bioactive compound sources such as plants and foods; nevertheless, it is necessary to standardize protocols used in vitro as well to properly scale them to animal models and clinical tests in order to have a better understanding of the mechanisms involved in overweight and obesity.

Keywords: 3T3-L1 cell line; adipocyte browning; bioactive compounds.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Cappa D.F. Tejido Adiposo: Anatomía y Estructura Básica-Darío Cappa Capacitaciones. PubliCE. 2012;2012:1–9.
    1. Snyder WCook M.J., Nasset E.S., Karhausen L.R., Howells G.P., Tipton I.H. International Commission on Radiological Protection. Volume 23. Pergamon Press; Oxford, UK: 1975. Report of the task group on reference men; pp. 419–420. Report of the Task Group on Reference Man; ICRP Publication 23.
    1. Parlee S.D., Lentz S.I., Mori H., MacDougald O.A. Quantifying size and number of adipocytes in adipose tissue. Methods Enzymol. 2014;537:93–122. - PMC - PubMed
    1. Harms M., Seale P. Brown and beige fat: Development, function and therapeutic potential. Nat. Med. 2013;19:1252–1263. doi: 10.1038/nm.3361. - DOI - PubMed
    1. Nosalski R., Guzik T.J. Perivascular adipose tissue inflammation in vascular disease. Br. J. Pharmacol. 2017;174:3496–3513. doi: 10.1111/bph.13705. - DOI - PMC - PubMed

LinkOut - more resources